11/20/2024
3:15 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:15 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
12:37 PM | Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:37 PM | Telomir Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:05 PM | Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/29/2024
3:05 PM | Telomir Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Del Giudice Matthew Paul (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/29/2024
3:05 PM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | MacPherson Edward Clouston (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:05 PM | Jerman Michael Allen (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
10:17 AM | Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
10:17 AM | MacPherson Edward Clouston (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
10:17 AM | Telomir Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
10:17 AM | Del Giudice Matthew Paul (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2024
3:31 PM | Telomir Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/29/2024
4:28 PM | Telomir Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/08/2024
11:15 PM | Telomir Pharmaceuticals (Filer)
| Form EFFECT | |
02/08/2024
4:46 PM | EAGLE CRAIG (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:48 PM | McColl Hugh III (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:52 PM | Jerman Michael Allen (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:55 PM | Fuentes Nathen (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:58 PM | Telomir Pharmaceuticals (Issuer)
Tuck Talhia (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
5:01 PM | Bay Shore Trust (Reporting)
McNulty Brian Patrick (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:34 PM | Kroenig Bradley (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:39 PM | Chapman Christopher C JR (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:40 PM | Nicholoudis Christos (Reporting)
Telomir Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
4:26 PM | Telomir Pharmaceuticals (Filer)
| Form 8-A12B | |
01/03/2024
9:50 AM | Telomir Pharmaceuticals (Filer)
| Form S-1/A | |
12/19/2023
4:19 PM | Telomir Pharmaceuticals (Filer)
| Form S-1/A | |
12/14/2023
4:09 PM | Telomir Pharmaceuticals (Filer)
| Form S-1/A | |
